Full analysis of the side effects of Osimertinib/Tagrisso: pay attention to discomfort reactions during treatment

Osimertinib/Tagrisso (Osimertinib) is a targeted drug for EGFR mutant non-small cell lung cancer. Since its launch, this drug has received widespread attention from patients and medical staff due to its unique efficacy. However, while any drug exerts its therapeutic effect, it may also be accompanied by certain side effects. Understanding the side effects of osimertinib is critical for patients to better manage these adverse reactions.

According to clinical research data, the most common side effects in patients using osimertinib include leukopenia, lymphopenia, thrombocytopenia, etc. Abnormalities in these laboratory indicators may affect the patient's immune system function and reduce their resistance to infection, thus requiring doctors to closely monitor blood indicators. If the patient develops fever or other symptoms of infection during treatment, he should seek medical treatment in time.

Diarrhea is a common digestive reaction after taking osimertinib, and some patients experience mild to moderate diarrhea in the weeks after starting treatment. Although most patients can tolerate these discomforts, if the diarrhea is severe or lasts for a long time, it will affect the patient's quality of life. Therefore, they should communicate with their doctor in time and take corresponding measures to deal with it if necessary.

Rash is another common side effect of osimertinib treatment, and patients may experience skin reactions on the trunk, face, or extremities. Although this type of rash is usually mild, for some patients it can cause significant discomfort. In this case, the doctor may recommend topical medications or other relief measures to help the patient reduce these symptoms. At the same time, keeping the skin clean and using gentle skin care products can also help reduce the occurrence of rashes.

Additionally, patients may experience fatigue while taking osimertinib, which is a common problem. The generation of fatigue may be related to the metabolism of drugs, the disease itself, and the patient's psychological state. Patients can cope with this fatigue through proper rest and nutritional supplements, while maintaining a positive attitude towards life and participating in some relaxing activities, which can help improve the overall mental state.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7